Submitted by Anonymous (not verified) on 2 September 2024 - 14:45
Human medicines European public assessment report (EPAR): Toujeo (previously Optisulin), insulin glargine, Date of authorisation: 26/06/2000, Revision: 36, Status: Authorised
Source: